New Approaches to Measuring Value in Oncology Therapy
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
3
No Surprises Act Arbitration Added $8.39B in 2025 Plan Obligations
4
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
5